Compare Agilent Technologies Inc (A) vs W W Grainger Inc (GWW) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Agilent Technologies Inc vs W W Grainger Inc — how do they compare? Agilent Technologies Inc trades at $128.71 (market cap $37.04B), while W W Grainger Inc trades at $1,346.5 (market cap $64.04B). The key difference: W W Grainger Inc is the larger of the two by market cap, and Agilent Technologies Inc pays the higher dividend (0.78%). Which is the better fit depends on your goals.
| A | GWW | |
|---|---|---|
Market Cap | $37.04B | $64.04B |
Sector | Health | Technology |
52-Week High | $157.20 | $1.37K |
52-Week Low | $110.24 | $918.18 |
Enterprise Value | $38.59B | $66.13B |
Dividend Yield | 0.78% | 0.68% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
GWW trades at $1,370.16, up 2.02% today, showing strong momentum with a bullish technical signal from moving averages. The company reported Q1 2026 EPS of $11.65, beating estimates by 14%, and raised full-year guidance. Revenue growth remains solid at 10.1% year-over-year, with operating margins expanding 110 basis points to 16.7%. Recent news highlights Grainger's 25-year partnership with the American Red Cross and multiple analyst upgrades citing momentum potential.
The outlook remains positive with analyst consensus target of $1,260 suggesting modest upside. Strong profitability metrics (48.1% ROE, 19.66% ROA) support valuation, though elevated P/E of 36.84 warrants monitoring. Key risks include industrial sector cyclicality and margin pressure from rising costs. Institutional sentiment leans cautious with 63% hold ratings despite recent earnings beat.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About W W Grainger Inc
Grainger is a leading broad-line distributor of maintenance, repair, and operating (MRO) products. It serves millions of customers worldwide through an integrated network of branches and digital platforms.
Read more on GWW →
